← Back to Search

Behavioural Intervention

Self-Distancing for Pediatric Anxiety and OCD

N/A
Waitlist Available
Led By Kate D Fitzgerald, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 3, 4, 5, 6, 7, 8, 9, 10
Awards & highlights

Summary

This trial is looking at a technique called Self-Distancing, which involves changing your perspective to a more objective view in emotionally charged situations. The study wants to see if using self-distancing can help

Who is the study for?
This trial is for children with anxiety disorders, OCD, or compulsive personality disorder. It's designed to see if a new way of thinking called self-distancing can help them better handle situations that scare them compared to classic exposure therapy.
What is being tested?
The study compares two methods: Self-Distancing (EXSD), where kids learn to shift their perspective in scary situations, and Classic Exposure (EXC), the usual way of facing fears directly. Researchers will measure how these techniques affect the children's willingness to face fears and their anxiety levels.
What are the potential side effects?
Since both interventions are psychological strategies rather than medications, they may not have typical 'side effects'. However, participating children might experience increased anxiety or distress temporarily when facing feared situations during therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 3, 4, 5, 6, 7, 8, 9, 10
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 3, 4, 5, 6, 7, 8, 9, 10 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Treatment Engagement and Adherence Ratings (TEARS)
Secondary study objectives
Anxiety Disorders Interview Schedule for DSM-5 (ADIS) Clinical Severity Rating (CSR)
Other study objectives
Child Yale-Brown Obsessive-Compulsive Scale (CY-BOCS)
Clinical Global Impression of Improvement (CGI-I) Scale
Clinical Global Impression of Severity (CGI-S) Scale
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Self-DistancingExperimental Treatment1 Intervention
Youth will be randomized to 10 weekly exposure therapy sessions. In the Self-Distanced arm, participants will be instructed to describe exposure tasks from a self-distanced perspective (e.g., "Emily is going to touch the dirty floor").
Group II: Classic ExposureActive Control1 Intervention
Youth will be randomized to 10 weekly exposure therapy sessions. In the Classic Exposure arm, participants will be instructed to describe exposure tasks from a self-immersed perspective (e.g.,"I'm going to touch a dirty floor")

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,471 Previous Clinical Trials
2,536,315 Total Patients Enrolled
9 Trials studying Anxiety Disorders
13,419 Patients Enrolled for Anxiety Disorders
Kate D Fitzgerald, MDPrincipal InvestigatorProfessor of Psychiatry
1 Previous Clinical Trials
48 Total Patients Enrolled
1 Trials studying Anxiety Disorders
48 Patients Enrolled for Anxiety Disorders
~23 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top